Luzi Andreas von Bidder
Chairman at EyeSense AG
Network origin in Luzi Andreas von Bidder first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 19 | |
12
| Public Company | Pharmaceuticals: Major | 12 |
Ferring International Center SA
 Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
EyeSense AG
 EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland.
8
| Holding Company | Medical Specialties | 8 |
Orasis Pharmaceuticals Ltd.
 Orasis Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Orasis Pharmaceuticals Ltd. operates as a clinical stage pharmaceutical company. It develops eye drops for the treatment of presbyopia as an alternative to reading glasses. The company was founded in 2015 and is headquartered in Herzliya, Israel.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Ferring Holding SA
 Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland.
3
| Private Company | Pharmaceuticals: Major | 3 |
Novartis Ophthalmics AG
1
| Subsidiary | 1 | |
Ferring Pharmaceuticals SA
 Ferring Pharmaceuticals SA BiotechnologyHealth Technology Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland.
1
| Subsidiary | Biotechnology | 1 |
Ixodes AG
 Ixodes AG Pharmaceuticals: MajorHealth Technology Ixodes AG develops, produces and markets pharmaceutical products. It operates as a pharmaceutical company that improves patient lives through technologies for the prevention of Lyme disease. The firm's product Ixogel, is a solution to prevent Lyme disease via a topical application of an antibiotic after a tick bite. The company was founded in 2007 and is headquartered in Zumikon, Switzerland.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Luzi Andreas von Bidder via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal President Director/Board Member | |
Ferring Pharmaceuticals Ltd.
 Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
EyeSense GmbH
 EyeSense GmbH Electronic Equipment/InstrumentsElectronic Technology EyeSense GmbH develops novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients. It is developing two different diagnostic systems: An ophthalmic sensor which-once inserted on the eye-can be read out optically as frequently as wanted, without any pain and a continuous sensor, to be worn on the abdomen or upper arm. The firm with its innovative sensor technology able to offer two products that addresses different needs in blood glucose monitoring which are Continuous Glucose Sensor and Eye Sensor. The company was founded in 2006 and is headquartered in Großostheim, Germany. | Electronic Equipment/Instruments | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| SPEXIS AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| HARROW, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TEARLAB CORPORATION | Medical Specialties | Director/Board Member Chief Operating Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Chairman Director/Board Member | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Uppsala | College/University | Masters Business Admin Graduate Degree | |
| SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Basel | College/University | Graduate Degree Graduate Degree | |
FinVector Oy
 FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Mepha AG
 Mepha AG Pharmaceuticals: MajorHealth Technology Mepha develops and makes interesting pharmaceuticals in Switzerland, as well as offering attractive services, so that doctors and pharmacists can treat their patients both more effectively and in a more price-conscious way. This is achieved by team work and innovative spirit, examples of which are as follows. Its innovative dosage forms are more readily accepted by patients, so the patient compliance is higher, which makes for a more effective treatment. It has been involved in the fight against malaria for over 20 years, and introduced a state-of-the-art combination drug with the active substances mefloquine and artesunate (Artequin™) on the international market in 2002 for the treatment of this disease. It can offer many creative services and target-oriented two-way communication to help its clients in the treatment of their patients. Its highly motivated employees add their friendly approach to its comprehensive portfolio for the benefit of its clients. | Pharmaceuticals: Major | Chief Operating Officer Director of Finance/CFO | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
NextPharma Germany TopCo GmbH
 NextPharma Germany TopCo GmbH Financial ConglomeratesFinance Part of NextPharma UK TopCo Ltd., NextPharma Germany TopCo GmbH is a pharmaceutical contract development and manufacturing organization serving worldwide markets. The company is based in Goettingen, Germany. The CEOs are Eric Schmidhäuser, Peter Arend William Burema. The German company was founded in 2017. | Financial Conglomerates | Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
NextPharma Technologies Holding Ltd.
 NextPharma Technologies Holding Ltd. Pharmaceuticals: MajorHealth Technology NextPharma Technologies Holding Ltd. operates as a pharmaceutical contract development and manufacturing firm. It specializes in modified release technologies and in product manufacturing including hormones, penicillin, and cephalosporin. The company was founded on January 2, 2003 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| York University | College/University | Masters Business Admin | |
Nextpharma Holdings Ltd.
 Nextpharma Holdings Ltd. Financial ConglomeratesFinance Nextpharma Holdings Ltd. functions as an investment holding company. The company is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
| McGill University | College/University | Undergraduate Degree | |
NextPharma Logistics GmbH
 NextPharma Logistics GmbH Air Freight/CouriersTransportation Part of NextPharma Technologies Holding Ltd., NextPharma Logistics GmbH provides logistics services. The company is based in Bielefeld, Germany. The CEOs of the German company are Christian Pieper, Peter Arend William Burema, Frederik Günther. | Air Freight/Couriers | Chief Executive Officer | |
Munir Sukhtian Pharmaceuticals
 Munir Sukhtian Pharmaceuticals Pharmaceuticals: MajorHealth Technology Munir Sukhtian Pharmaceuticals engages in the manufacturing and distribution of pharmaceuticals. It undertakes marketing and branding of products for infections, obstetrics, gynecology and urinary tract disorders, and cardiovascular and musculoskeletal diseases. The company was founded in 1989 and is headquartered in Amman, Jordan. | Pharmaceuticals: Major | Director/Board Member | |
| Bowtie Germany Topco GmbH | Chief Executive Officer | ||
PHARBIL Pharma GmbH
 PHARBIL Pharma GmbH Pharmaceuticals: MajorHealth Technology Part of NextPharma Technologies Holding Ltd., PHARBIL Pharma GmbH is a German company that manufactures pharmaceutical preparations. The company is based in Bielefeld, Germany. The CEO of the company is Peter Arend William Burema. | Pharmaceuticals: Major | Chief Executive Officer | |
NextPharma UK MidCo Ltd.
 NextPharma UK MidCo Ltd. Financial ConglomeratesFinance Part of NextPharma UK TopCo Ltd., NextPharma UK MidCo Ltd. functions as an investment holding company. The company is based in Woking, UK and was founded in 2017. | Financial Conglomerates | Director/Board Member | |
NextPharma UK TopCo Ltd.
 NextPharma UK TopCo Ltd. Pharmaceuticals: MajorHealth Technology NextPharma UK TopCo Ltd. is a pharmaceutical contract development and manufacturing organization founded in 2017. The British company serves worldwide markets and specializes in providing pharmaceutical services. | Pharmaceuticals: Major | Director/Board Member | |
Allphamed Pharbil Arzneimittel GmbH
 Allphamed Pharbil Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Part of NextPharma Technologies Holding Ltd., Allphamed Pharbil Arzneimittel GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Goettingen, Germany. The CEO of the company is Peter Arend William Burema. | Pharmaceuticals: Major | Chief Executive Officer | |
NextPharma Germany BidCo GmbH
 NextPharma Germany BidCo GmbH Financial ConglomeratesFinance Part of NextPharma UK TopCo Ltd., NextPharma Germany BidCo GmbH is a pharmaceutical contract development and manufacturing organization serving worldwide markets. The company is based in Goettingen, Germany. The CEOs of the German company are Peter Arend William Burema, Eric Schmidhäuser. | Financial Conglomerates | Chief Executive Officer | |
NextPharma Germany ParentCo GmbH
 NextPharma Germany ParentCo GmbH Chemicals: SpecialtyProcess Industries Part of NextPharma UK TopCo Ltd., NextPharma Germany ParentCo GmbH manufactures and wholesales chemical products. The company is based in Goettingen, Germany. The CEOs are Eric Schmidhäuser, Peter Arend William Burema. The German company was founded in 2017. | Chemicals: Specialty | Chief Executive Officer | |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Consultant / Advisor | |
| EVOLVA HOLDING SA | Food: Specialty/Candy | Director/Board Member | |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree | |
| ROQUEFORT THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| Ferring Research Ltd. | Director/Board Member | ||
| Ferring Properties SA | Director/Board Member |
Statistics
International
| United States | 14 |
| Germany | 10 |
| Switzerland | 10 |
| United Kingdom | 9 |
| Denmark | 4 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 8 |
| Finance | 6 |
| Electronic Technology | 2 |
| Transportation | 2 |
Operational
| Director/Board Member | 286 |
| Corporate Officer/Principal | 101 |
| Chairman | 65 |
| Independent Dir/Board Member | 59 |
| Chief Executive Officer | 56 |
Most connected contacts
| Insiders | |
|---|---|
| Adrienne Graves | 38 |
| Hélène Ploix | 31 |
| David Ben-Ami | 30 |
| Birgit Stattin Norinder | 29 |
| Hans-Peter Hasler | 28 |
| Vaughn M. Kailian | 27 |
| Peter Arend William Burema | 23 |
| Karl Härfstrand | 23 |
| Lars Rebien Sørensen | 22 |
| Jean Duvall | 22 |
| Andreas Rummelt | 18 |
| Jean-François Labbé | 18 |
| Michele Garufi | 17 |
| Yoav Shaked | 17 |
| Andreas Segerros | 17 |
- Stock Market
- Insiders
- Luzi Andreas von Bidder
- Company connections
